Cellosaurus TCC-Y/sr (CVCL_D3Z5)
| Cell line name | TCC-Y/sr |
|---|---|
| Synonyms | TCC-Y / sr |
| Accession | CVCL_D3Z5 |
| Resource Identification Initiative | To cite this cell line use: TCC-Y/sr (RRID:CVCL_D3Z5) |
| Comments | Group: Patented cell line. Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-8531. Population: Japanese. Doubling time: 34 +- 4 hours (Patent=WO2004094628A1). Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571). Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. |
| Sequence variations |
|
| Disease | Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1 (NCIt: C114819) B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) (ORDO: Orphanet_585909) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_D3Z4 (TCC-Y) |
| Sex of cell | Sex unspecified |
| Age at sampling | Adult |
| Category | Cancer cell line |
| Publications | Patent=WO2004094628A1 |
| Cross-references | |
| Encyclopedic resources | Wikidata; Q127384378 |
| Entry history | |
| Entry creation | 30-Jan-2024 |
| Last entry update | 19-Dec-2024 |
| Version number | 3 |